Search results for " T-Lymphocytes"

showing 10 items of 495 documents

Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.

1999

Myelin basic protein (MBP)-reactive T cells may play an important role in the autoimmune pathogenesis of multiple sclerosis (MS). MBP-reactive T cells can be specifically targeted by T cell vaccination, a procedure whereby MS patients are immunized with attenuated autologous MBP reactive T cells. T cell vaccination induces immune responses to the vaccine cells together with a depletion of MBP reactive T cells. Forty-nine MS patients were treated with T cell vaccination in an extended phase I trial to study the safety, immune responses and clinical effects of T cell vaccination. In the present paper the immune responses towards the vaccine cells were characterized. Substantial long-term in v…

CD4-Positive T-LymphocytesMultiple SclerosisT-LymphocytesImmunologyT-cell vaccinationLymphocyte ActivationInterleukin 21Immunology and AllergyMedicineCytotoxic T cellHumansIL-2 receptorAntigen-presenting cellImmunity CellularVaccinesCD40biologyClinical Trials Phase I as Topicbusiness.industryVaccinationMyelin Basic ProteinNatural killer T cellLymphocyte SubsetsVaccines InactivatedCTLA-4ImmunologyAntibody Formationbiology.proteinCytokinesImmunotherapybusinessJournal of autoimmunity
researchProduct

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

2003

AbstractCoupling of ovalbumin (OVA) to anti–DEC-205 monoclonal antibody (mAb) (αDEC) induced the proliferation of OVA-specific T cells in vivo. Expansion was short-lived, caused by dendritic cells (DCs), and rendered T cells anergic thereafter. Phenotypic analysis revealed the induction of CD25+/CTLA-4+ T cells suppressing proliferation and interleukin-2 (IL-2) production of effector CD4+ T cells. The findings were supported by 2 disease models: (1) CD4+ T-cell–mediated hypersensitivity reactions were suppressed by the injection of αDEC-OVA and (2) the application of hapten-coupled αDEC-205 reduced CD8+ T-cell–mediated allergic reactions. Thus, targeting of antigens to immature DCs through …

CD4-Positive T-LymphocytesOvalbuminT-LymphocytesImmunologyCD8-Positive T-LymphocytesDermatitis ContactLymphocyte ActivationBiochemistryMiceInterleukin 21Antigens CDHypersensitivityAnimalsCytotoxic T cellCTLA-4 AntigenHypersensitivity DelayedLymphocyte CountIL-2 receptorAntigensAntigen-presenting cellAntigen PresentationMice Inbred BALB CCD40biologyAntibodies MonoclonalReceptors Interleukin-2Dendritic CellsCell BiologyHematologyDendritic cellNatural killer T cellAntigens DifferentiationCell biologyImmunologyInterleukin 12biology.proteinInterleukin-2HaptensBlood
researchProduct

PD-1 signalling in CD4+T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolera…

2010

Summary The ultimate outcome of T-cell recognition of peptide–major histocompatibility complex (MHC) complexes is determined by the molecular context in which antigen presentation is provided. The paradigm is that, after exposure to peptides presented by steady-state dendritic cells (DCs), inhibitory signals dominate, leading to the deletion and/or functional inactivation of antigen-reactive T cells. This has been utilized in a variety of models providing peptide antigen in soluble form in the absence of adjuvant. A co-inhibitory molecule of considerable current interest is PD-1. Here we show that there is the opportunity for the PD-1/PD-L1 interaction to function in inhibiting the T-cell r…

CD4-Positive T-LymphocytesOvalbuminTransgeneProgrammed Cell Death 1 ReceptorImmunologyAntigen presentationMice TransgenicCell SeparationCD8-Positive T-LymphocytesBiologyLymphocyte ActivationMajor histocompatibility complexMiceImmune systemBlocking antibodyImmune ToleranceAnimalsImmunology and AllergyT-cell receptorOriginal ArticlesFlow CytometryAntigens DifferentiationPeptide FragmentsCell biologyMice Inbred C57BLTolerance inductionPhenotypeImmunologybiology.proteinCD8Signal TransductionImmunology
researchProduct

TLR2 and Dectin-1 Signaling in Mouse Hematopoietic Stem and Progenitor Cells Impacts the Ability of the Antigen Presenting Cells They Produce to Acti…

2020

Microbial recognition by pattern recognition receptors (PRRs) expressed on hematopoietic stem and progenitor cells (HSPCs) not only activates myelopoiesis but also programs the function of the monocytes and macrophages they produce. For instance, changes in HSPC programming modify the ability of macrophages derived from them to produce inflammatory cytokines. While HSPCs exposed to a TLR2 agonist give rise to tolerized macrophages (lower proinflammatory cytokine production), HSPCs treated with Dectin-1 ligands produce trained macrophages (higher proinflammatory cytokine production). However, nothing is known about the impact of HSPC exposure to microbes on the function of antigen presenting…

CD4-Positive T-LymphocytesOvalbuminhematopoietic stem and progenitor cellsCD4 T cellsAntigen-Presenting CellsMice Transgenicantigen presenting cellsLymphocyte Activationinnate immune memoryProinflammatory cytokineLipopeptidesCandida albicansAnimalsTLR2Lectins C-TypeProgenitor cellAntigen-presenting celllcsh:QH301-705.5CD86CD40biologyChemistryCommunicationHistocompatibility Antigens Class IIZymosanGeneral MedicineTh1 CellsHematopoietic Stem CellsAcquired immune systemToll-Like Receptor 2Cell biologyMice Inbred C57BLlcsh:Biology (General)biology.proteinCytokinesTh17 CellsMyelopoiesisCD80Dectin-1Signal TransductionCells
researchProduct

Characterization of T–cell subclasses and NK–cells in lysosomal disorders by immuno–electron microscopy

1994

Previous studies have shown that B and T lymphocytes are affected in lysosomal disorders. The aim of this study was to investigate the involvement of subclasses of T lymphocytes and natural killer cells in lysosomal diseases. CD4+, CD8+, and CD56+ cells were immunomagnetically separated from peripheral blood mononuclear cells in 10 patients with various lysosomal diseases--including one patient each with infantile, late infantile, and juvenile neuronal ceroid-lipfuscinoses, two patients with mucopolysaccharidosis (MPS) type I and four patients with MPS type III, and one patient with mucolipidosis type II; all lymphocytes were studied by light and electron microscopy. Respective vacuolar or …

CD4-Positive T-LymphocytesPathologymedicine.medical_specialtyHistologyT-LymphocytesMucopolysaccharidosisT cellImmunoblottingCD8-Positive T-LymphocytesBiologyPathology and Forensic MedicineNatural killer cellPhysiology (medical)Lysosomal storage diseasemedicineHumansMicroscopy ImmunoelectronT lymphocyteMucopolysaccharidosesmedicine.diseaseKiller Cells Naturalmedicine.anatomical_structureNeurologyNeuronal ceroid lipofuscinosisNeurology (clinical)I-cell diseaseLysosomesCD8Neuropathology and Applied Neurobiology
researchProduct

Miltefosine Efficiently Eliminates Leishmania major Amastigotes from Infected Murine Dendritic Cells without Altering Their Immune Functions▿

2009

ABSTRACT As a treatment for leishmaniasis, miltefosine exerts direct toxic effects on the parasites. Miltefosine also modulates immune cells such as macrophages, leading to parasite elimination via oxidative radicals. Dendritic cells (DC) are critical for initiation of protective immunity against Leishmania through induction of Th1 immunity via interleukin 12 (IL-12). Here, we investigated the effects of miltefosine on DC in Leishmania major infections. When cocultured with miltefosine for 4 days, the majority of in vitro -infected DC were free of parasites. Miltefosine treatment did not influence DC maturation (upregulation of major histocompatibility complex II [MHC II] or costimulatory m…

CD4-Positive T-LymphocytesPhosphorylcholineAntigen presentationAntiprotozoal AgentsLeishmaniasis CutaneousApoptosisBiologyCD8-Positive T-LymphocytesMicrobiologyMiceImmune systemmedicineAnimalsPharmacology (medical)Leishmania majorAntigen-presenting cellMechanisms of Action: Physiological EffectsCells CulturedCell ProliferationLeishmania majorPharmacologyMiltefosineDendritic cellDendritic Cellsbiology.organism_classificationLeishmaniaMice Inbred C57BLInfectious DiseasesImmunologyInterleukin 12medicine.drug
researchProduct

Functionalized Polystyrene Nanoparticles Trigger Human Dendritic Cell Maturation Resulting in Enhanced CD4+T Cell Activation

2012

Nanoparticles (NP) represent a promising tool for biomedical applications. Here, sulfonate- and phosphonate-functionalized polystyrene NP are analyzed for their interaction with human monocyte-derived dendritic cells (DC). Immature dendritic cells (iDC) display a higher time- and dose-dependent uptake of functionalized polystyrene NP compared to mature dendritic cells (mDC). Notably, NP induce an enhanced maturation of iDC but not of mDC (upregulation of stimulatory molecules and cytokines). NP-triggered maturation results in a significantly enhanced T cell stimulatory capacity (increased CD4(+) T cell proliferation and IFN-γ production), indicating a shift to a pronounced Th1 response. Imm…

CD4-Positive T-LymphocytesPolymers and Plasticsmedicine.medical_treatmentT cellOrganophosphonatesNanoparticleBioengineeringLymphocyte ActivationFunctionalized polystyreneBiomaterialsInterferon-gammachemistry.chemical_compoundDownregulation and upregulationMaterials ChemistrymedicineHumansImmunologic FactorsMicroscopy ConfocalCd4 t cellChemistryDendritic CellsImmunotherapyDendritic cellCell biologymedicine.anatomical_structureImmunologyCytokinesNanoparticlesPolystyrenesPolystyreneSulfonic AcidsBiotechnologyMacromolecular Bioscience
researchProduct

Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.

2005

CD8+ T cells have a crucial role in resistance to pathogens and can kill malignant cells; however, some critical functions of these lymphocytes depend on helper activity provided by a distinct population of CD4+ T cells. Cooperation between these lymphocyte subsets involves recognition of antigens co-presented by the same dendritic cell, but the frequencies of such antigen-bearing cells early in an infection and of the relevant naive T cells are both low. This suggests that an active mechanism facilitates the necessary cell-cell associations. Here we demonstrate that after immunization but before antigen recognition, naive CD8+ T cells in immunogen-draining lymph nodes upregulate the chemok…

CD4-Positive T-LymphocytesReceptors CCR5T cellAntigen presentationCell CommunicationBiologyCD8-Positive T-LymphocytesLymphocyte ActivationInterleukin 21MiceCell MovementmedicineCell AdhesionCytotoxic T cellAnimalsAntigen-presenting cellChemokine CCL4Chemokine CCL3MultidisciplinaryCD28Dendritic cellDendritic CellsMacrophage Inflammatory ProteinsNatural killer T cellmedicine.anatomical_structureChemokines CCImmunologyLymph NodesChemokinesImmunologic MemoryNature
researchProduct

Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with me…

2011

Background HLA mismatch antigens are major targets of alloreactive T cells in HLA-incompatible stem-cell transplantation, which can trigger severe graft- versus -host disease and reduce survival in transplant recipients. Our objective was to identify T-cell subsets with reduced in vitro reactivity to allogeneic HLA antigens. Design and Methods We sorted CD4 and CD8 T-cell subsets from peripheral blood by flow cytometry according to their expression of naive and memory markers CD45RA, CD45RO, CD62L, and CCR7. Subsets were defined by a single marker to facilitate future establishment of a clinical-grade procedure for reducing alloreactive T-cell precursors and graft- versus -host disease. T c…

CD4-Positive T-LymphocytesReceptors CCR7LymphocyteT-LymphocytesGraft vs Host DiseaseHuman leukocyte antigenBiologyCD8-Positive T-LymphocytesInterleukin 21AntigenHLA AntigensCell Line TumormedicineCytotoxic T cellHumansTransplantation HomologousPrecursor Cells T-LymphoidLeukemiaCD28HematologyT lymphocyteOriginal ArticlesTissue Donorsmedicine.anatomical_structureImmunologyImmunotherapyK562 CellsImmunologic MemoryCD8Haematologica
researchProduct

Regulation of Protein-DNA Interactions at the Interferon-gamma Gene Promoter by Corticosteroids: Implications for Inflammatory Bowel Diseases

1998

CD4-Positive T-LymphocytesRecombinant Fusion ProteinsProtein dnaInterferon-gamma biosynthesisTransfectionGeneral Biochemistry Genetics and Molecular BiologyInterferon-gammaHistory and Philosophy of ScienceAdrenal Cortex HormonesGenes ReporterT-Lymphocyte SubsetsmedicineHumansInterferon gammaPromoter Regions GeneticGenebusiness.industryGeneral NeuroscienceInflammatory Bowel DiseasesPromoterTransfectionInflammatory Bowel DiseasesTranscription Factor AP-1ImmunologyLeukocyte Common AntigensCancer researchLeukocyte Common Antigensbusinessmedicine.drugAnnals of the New York Academy of Sciences
researchProduct